by PEAK Medicals | 18 December 2025
2025 Year in Review DRUGGABLE SINCE 2025: New Approvals and Emerging Options Solange Peters The Year of SCLC: From hope to practice Charles Rudin Highlights in Targeted Therapies and ADCs Martin Reck  18 December 2025 } 1 h 49 min Get Certificate This session was...
by PEAK Medicals | 26 September 2025
TAILORING IO IN RES. NSCLC: PERSONALIZED APPROACHES FOR IMPROVED OUTCOMES Patrick Forde (Dublin)  } 36 min Download...
by PEAK Medicals | 26 September 2025
Open Discussion on Patient Cases Panel Discussion With All  } 22...
by PEAK Medicals | 10 July 2025
Targeted Therapies in NSCLC Current Standards and Challenges in ALK+ and EGFR+ NSCLC Oliver Gautschi Unlocking Synergies with Chemo, Bispecifics and TKIs Jarushka Naidoo LATEST ADVANCES IN RECURRENT EGFR+ NSCLC: FOCUS ON MET Nicolas Girard  10 JULY 2025 } 1 h 30 min...
by PEAK Medicals | 25 June 2025
IO in early stage & combinations in late NSCLC LESS IS MORE – NEOADJUVANT IO ALONE IS UNDOUBTEDLY SUFFICIENT Patrick Forde EMBRACING ADDITIONAL ADJUVANT IO: A CRUCIAL AND NECESSARY ADD-ON Jordi Remon MAXIMIZING OUTCOMES: THE ROLE OF IO COMBINATIONS Solange Peters...
